Johns Hopkins HIV Guide
HMG CoA Reductase Inhibitors ("Statins")
HMG CoA Reductase Inhibitors ("Statins") is a topic covered in the Johns Hopkins HIV Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Atherosclerosis: fluvastatin, lovastatin
- Cardiovascular events (secondary prevention): pravastatin; coronary heart disease (primary prevention): pravastatin, simvastatin, fluvastatin, lovastatin
- Stroke / TIA (prophylaxis): simvastatin, rosuvastatin, atorvastatin
- Hypercholesterolemia, heterozygous familial: pravastatin (pediatrics), fluvastatin, atorvastatin, lovastatin, rosuvastatin; hypercholesterolemia, homozygous familial: simvastatin, atorvastatin, rosuvastatin
- Hypercholesterolemia (primary): fluvastatin, rosuvastatin, lovastatin, atorvastatin; hypertriglyceridemia: atorvastatin, rosuvastatin
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Hyperlipidemia associated with ART
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Atherosclerosis: fluvastatin, lovastatin
- Cardiovascular events (secondary prevention): pravastatin; coronary heart disease (primary prevention): pravastatin, simvastatin, fluvastatin, lovastatin
- Stroke / TIA (prophylaxis): simvastatin, rosuvastatin, atorvastatin
- Hypercholesterolemia, heterozygous familial: pravastatin (pediatrics), fluvastatin, atorvastatin, lovastatin, rosuvastatin; hypercholesterolemia, homozygous familial: simvastatin, atorvastatin, rosuvastatin
- Hypercholesterolemia (primary): fluvastatin, rosuvastatin, lovastatin, atorvastatin; hypertriglyceridemia: atorvastatin, rosuvastatin
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Hyperlipidemia associated with ART
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: September 3, 2016
Citation
Smith, Janessa M, and Paul A Pham. "HMG CoA Reductase Inhibitors ("Statins")." Johns Hopkins HIV Guide, 2016. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545193/all/HMG_CoA_Reductase_Inhibitors__"Statins"_.
Smith JM, Pham PA. HMG CoA Reductase Inhibitors ("Statins"). Johns Hopkins HIV Guide. 2016. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545193/all/HMG_CoA_Reductase_Inhibitors__"Statins"_. Accessed January 16, 2021.
Smith, J. M., & Pham, P. A. (2016). HMG CoA Reductase Inhibitors ("Statins"). In Johns Hopkins HIV Guide Retrieved January 16, 2021, from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545193/all/HMG_CoA_Reductase_Inhibitors__"Statins"_
Smith JM, Pham PA. HMG CoA Reductase Inhibitors ("Statins") [Internet]. In: Johns Hopkins HIV Guide. ; 2016. [cited 2021 January 16]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545193/all/HMG_CoA_Reductase_Inhibitors__"Statins"_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - HMG CoA Reductase Inhibitors ("Statins")
ID - 545193
A1 - Smith,Janessa,PharmD, BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2016/09/03/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545193/all/HMG_CoA_Reductase_Inhibitors__"Statins"_
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
